Signal active
Organization
Contact Information
Overview
Procella Therapeutics is an early stage biotechnology company that develop a cardiac stem cell therapy for patients with advanced heart failure.
About
Biotechnology, Therapeutics
2018
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Procella Therapeutics headquartered in Europe, operates in the Biotechnology, Therapeutics sector. With a team of 11-50 employees, Procella Therapeutics is actively contributing to advancements in Biotechnology. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
0
0
0
$0
Details
0
Procella Therapeutics has raised a total of $0 in funding over 0 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|
Investors
There is no investor info for this profile.
Recent Activity
There is no recent news or activity for this profile.